OpenURL Connection Search

Select item for more details and to access through your institution.

Using the CYP3A Activity Evaluation to Predict the Efficacy and Safety of Diazepam in Patients With Alcohol Withdrawal Syndrome.
Published in:
Journal of Pharmacy Practice, 2022, v. 35, n. 4, p. 518, doi. 10.1177/0897190021997000
By:
- Skryabin, Valentin Yu.;
- Zastrozhin, Mikhail S.;
- Grishina, Elena A.;
- Ryzhikova, Kristina A.;
- Shipitsyn, Valery V.;
- V. Barna, Ilya;
- Galaktionova, Tatiana E.;
- Ivanov, Andrey V.;
- Sorokin, Alexander S.;
- Bryun, Evgeny A.;
- Sychev, Dmitry A.
Publication type:
Article
Translating and adapting the Alcohol Use Disorders Identification Test (AUDIT) for use in the Russian Federation: A multicentre pilot study to inform validation procedures.
Published in:
Nordic Studies on Alcohol & Drugs / Nordisk Alkohol- & Narkotikatidskrift, 2023, v. 40, n. 5, p. 536, doi. 10.1177/14550725231183236
By:
- Neufeld, Maria;
- Bunova, Anna;
- Fadeeva, Eugenia;
- Nadezhdin, Alexey;
- Tetenova, Elena;
- Vyshinsky, Konstantin;
- Ferreira-Borges, Carina;
- Yurasova, Elena;
- Allenov, Andrey;
- Gornyi, Boris;
- Ivanova, Ekaterina;
- Kalinina, Anna;
- Kontsevaya, Anna;
- Bryun, Evgeny;
- Drapkina, Oxana;
- Gil, Artyom;
- Khalfin, Ruslan;
- Koshkina, Evgenia;
- Khaltourina, Daria;
- Madyanova, Viktoria
Publication type:
Article
Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.
Published in:
Pharmacogenomics & Personalized Medicine, 2018, v. 11, p. 113, doi. 10.2147/PGPM.S160763
By:
- Zastrozhin, Mikhail Sergeevich;
- Grishina, Elena Anatolievna;
- Denisenko, Nataliya Petrovna;
- Skryabin, Valentin Yurievich;
- Markov, Dmitry Dmitrievich;
- Savchenko, Ludmila Mikhailovna;
- Bryun, Evgeny Alekseevich;
- Sychev, Dmitry Alekseevich
Publication type:
Article
Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder.
Published in:
Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 209, doi. 10.2147/PGPM.S140700
By:
- Zastrozhin, Mikhail Sergeevich;
- Brodyansky, Vadim Markovich;
- Skryabin, Valentin Yurievich;
- Grishina, Elena Anatolievna;
- Ivashchenko, Dmitry Vladimirovich;
- Ryzhikova, Kristina Anatolievna;
- Savchenko, Ludmila Mikhaylovna;
- Kibitov, Alexander Olegovich;
- Bryun, Evgeny Alekseevich;
- Sychev, Dmitry Alekseevich
Publication type:
Article
The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction.
Published in:
Pharmacogenomics & Personalized Medicine, 2016, v. 9, p. 89, doi. 10.2147/PGPM.S110385
By:
- Sychev, Dmitry Alekseevich;
- Zastrozhin, Mikhail Sergeevich;
- Smirnov, Valery Valerieevich;
- Grishina, Elena Anatolievna;
- Savchenko, Ludmila Mikhailovna;
- Bryun, Evgeny Alekseevich
Publication type:
Article
Effects of <i>CYP2D6*4</i> polymorphism on the steady-state concentration of paroxetine in patients diagnosed with depressive episode and comorbid alcohol use disorder.
Published in:
2022
By:
- Zastrozhin, Mikhail;
- Skryabin, Valentin;
- Petukhov, Aleksey;
- Pankratenko, Elena;
- Pozdniakov, Sergei;
- Ivanchenko, Valentina;
- Horyaev, Denis;
- Vlasovskih, Roman;
- Bryun, Evgeny;
- Sychev, Dmitry
Publication type:
journal article
Using a pharmacogenetic clinical decision support system to improve psychopharmacotherapy dosing in patients with affective disorders.
Published in:
Drug Metabolism & Personalized Therapy, 2020, v. 35, n. 4, p. 1, doi. 10.1515/dmpt-2019-0033
By:
- Zastrozhin, Michael;
- Skryabin, Valentin;
- Sorokin, Alexander;
- Buzik, Oleg;
- Bedina, Inessa;
- Grishina, Elena;
- Ryzhikova, Kristina;
- Shipitsyn, Valery;
- Bryun, Evgeny;
- Sychev, Dmitry
Publication type:
Article
How do CYP2C19*2 and CYP2C19*17 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome?
Published in:
Drug Metabolism & Personalized Therapy, 2020, v. 35, n. 1, p. 1, doi. 10.1515/dmpt-2019-0026
By:
- Skryabin, Valentin Yu;
- Zastrozhin, Mikhail S.;
- Torrado, Marco V.;
- Grishina, Elena A.;
- Ryzhikova, Kristina A.;
- Shipitsyn, Valery V.;
- Galaktionova, Tatiana E.;
- Sorokin, Alexander S.;
- Bryun, Evgeny A.;
- Sychev, Dmitry A.
Publication type:
Article
Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.
Published in:
Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 4, p. 187, doi. 10.1515/dmpt-2018-0019
By:
- Zastrozhin, Michael S.;
- Antonenko, Anastasiya P.;
- Nesterenko, Elena V.;
- Seyfullaeva, Leyla I.;
- Mustafina, Violetta R.;
- Esakova, Antonina P.;
- Grishina, Elena A.;
- Sorokin, Alexandr S.;
- Skryabin, Valentin Yu.;
- Savchenko, Ludmila M.;
- Bryun, Evgeny A.;
- Sychev, Dmitry A.
Publication type:
Article
Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.
Published in:
Drug Metabolism & Personalized Therapy, 2017, v. 32, n. 3, p. 129, doi. 10.1515/dmpt-2017-0021
By:
- Sychev, Dmitry A.;
- Zastrozhin, Mikhail S.;
- Miroshnichenko, Igor I.;
- Baymeeva, Natalia V.;
- Smirnov, Valery V.;
- Grishina, Elena A.;
- Ryzhikova, Kristina A.;
- Mirzaev, Karin B.;
- Markov, Dmitry D.;
- Skryabin, Valentin Y.;
- Snalina, Nataliya E.;
- Nosikova, Polina G.;
- Savchenko, Ludmila M.;
- Bryun, Evgeny A.
Publication type:
Article
Association between the Alcohol Biomarker Phosphatidylethanol (PEth) and Self-Reported Alcohol Consumption among Russian and Norwegian Medical Patients.
Published in:
Alcohol & Alcoholism, 2021, v. 56, n. 6, p. 726, doi. 10.1093/alcalc/agab013
By:
- Jørgenrud, Benedicte;
- Kabashi, Saranda;
- Nadezhdin, Aleksei;
- Bryun, Evgeny;
- Koshkina, Evgenya;
- Tetenova, Elena;
- Lerdal, Anners;
- Norby, Gudmund;
- Kolgashkin, Alexey;
- Petukhov, Alexei;
- Perekhodov, Sergey;
- Davydova, Elena;
- Vindenes, Vigdis;
- Gamboa, Danil;
- Bogstrand, Stig Tore
Publication type:
Article
Investigating the Use of Pharmacogenetic and Pharmacometabolomic Markers to Predict Haloperidol Efficacy and Safety Rates.
Published in:
Hospital Pharmacy, 2023, v. 58, n. 4, p. 363, doi. 10.1177/00185787231155842
By:
- Skryabin, Valentin Yurievich;
- Zastrozhin, Mikhail Sergeevich;
- Parkhomenko, Aleksandra Aleksandrovna;
- Pankratenko, Ekaterina Petrovna;
- Pozdnyakov, Sergei Aleksandrovich;
- Denisenko, Natalia Pavlovna;
- Akmalova, Kristina Anatolyevna;
- Bryun, Evgeny Alekseevich;
- Sychev, Dmitry Alekseevich
Publication type:
Article
Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome.
Published in:
Hospital Pharmacy, 2021, v. 56, n. 5, p. 592, doi. 10.1177/0018578720931756
By:
- Skryabin, Valentin Yurievich;
- Zastrozhin, Mikhail;
- Torrado, Marco;
- Grishina, Elena;
- Ryzhikova, Kristina;
- Shipitsyn, Valery;
- Galaktionova, Tatiana;
- Sorokin, Alexander;
- Bryun, Evgeny;
- Sychev, Dmitry
Publication type:
Article
Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.
Published in:
Human Psychopharmacology: Clinical & Experimental, 2018, v. 33, n. 6, p. N.PAG, doi. 10.1002/hup.2677
By:
- Zastrozhin, Michael S.;
- Sorokin, Aleksandr S.;
- Agibalova, Tatyana V.;
- Grishina, Elena A.;
- Antonenko, Anastasiya Р.;
- Rozochkin, Ilya N.;
- Duzhev, Denis V.;
- Skryabin, Valentine Y.;
- Galaktionova, Tatyana E.;
- Barna, Ilya V.;
- Orlova, Anna V.;
- Aguzarov, Albert D.;
- Savchenko, Ludmila M.;
- Bryun, Evgeny A.;
- Sychev, Dmitry A.
Publication type:
Article

Found: 14

Using the CYP3A Activity Evaluation to Predict the Efficacy and Safety of Diazepam in Patients With Alcohol Withdrawal Syndrome.

Translating and adapting the Alcohol Use Disorders Identification Test (AUDIT) for use in the Russian Federation: A multicentre pilot study to inform validation procedures.

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder.

The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction.

Effects of <i>CYP2D6*4</i> polymorphism on the steady-state concentration of paroxetine in patients diagnosed with depressive episode and comorbid alcohol use disorder.

Using a pharmacogenetic clinical decision support system to improve psychopharmacotherapy dosing in patients with affective disorders.

How do CYP2C192 and CYP2C1917 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome?

Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.

Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.

Association between the Alcohol Biomarker Phosphatidylethanol (PEth) and Self-Reported Alcohol Consumption among Russian and Norwegian Medical Patients.

Investigating the Use of Pharmacogenetic and Pharmacometabolomic Markers to Predict Haloperidol Efficacy and Safety Rates.

Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome.

Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.